Assessment of Nociceptive Processing Among Patients With Temporo-mandibular Disorders
Assessment of Generalized Alterations in Nociceptive Processing Among Patients Presenting With Temporo-mandibular Disorders
1 other identifier
interventional
40
1 country
1
Brief Summary
This case control study will investigate the physiological effect of nociceptive input in individuals with temporomandibular disorders. To do so, the investigators will compare the development of secondary hyperalgesia following high frequency electrical stimulation (HFS) of skin nociceptors in the forearms for up to 48 hours in individuals with chronic TMD (as a main complain) and in healthy controls. Furthermore, the investigators will evaluate the association between the response to HFS and various factors, such as demographic, psychosocial and pain-related clinical factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2019
CompletedFirst Posted
Study publicly available on registry
September 12, 2019
CompletedStudy Start
First participant enrolled
January 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2022
CompletedApril 7, 2022
March 1, 2022
1.2 years
August 22, 2019
March 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The extent of secondary hyperalgesia on the forearm in the proximo-distal direction 45 minutes after HFS
The area of secondary hyperalgesia (cm square) will be assessed with a calibrated 128 millinewton pinprick probe. Pokes of 1-second duration will be provided at a frequency of 0.5 Hz, starting well outside and approaching the stimulation site with steps of 0,5 cm from 4 different directions towards the application site. Participants will be asked to keep their eyes closed during the entire mapping procedure
After HFS and the assessment of pain resulting from pinprick stimulation and allodynia (time 7). This outcome is taken at day 1 at time 7.
Secondary Outcomes (21)
Age
During the initial evaluation (time 1). This outcome is taken at day 1 at time 1.
Weight
At baseline (time 1). This outcome is taken at day 1 at time 1.
Height
At baseline (time 1). This outcome is taken at day 1 at time 1.
The TMD diagnosis according to the diagnostic criteria for temporomandibular disorders (DC/TMD)
At baseline (time 1). This outcome is taken at day 1 at time 1.
Graded chronic pain scale
At baseline (time 1) and 6 months after the initial assessment (time 10). This outcome is taken at day 1 at time 1 and day 180 at time 10.
- +16 more secondary outcomes
Study Arms (2)
Temporomandibular disorder
EXPERIMENTALHealthy control
EXPERIMENTALInterventions
High-frequency stimulation will be applied on the volar forearm (6-10 cm distal to the cubital fossa). To avoid any confounding effect of handedness, the arm onto which HFS will be applied twice (dominant vs nondominant) will be counterbalanced across participants. HFS will consist of 12 trains of 42 Hz electrical pulses lasting 1 s each. The time interval between each train will be 10 s. The intensity of stimulation will be milliampere. Electrical pulses will be delivered to the skin using a specifically-designed electrode designed: the cathode consists of 16 blunt stainless-steel pins with a diameter of 0.2 mm protruding 1 mm from the base. The 16 pins are placed in a circle with a diameter of 10 mm. The anode consists of a surrounding stainless-steel ring having an inner diameter of 22 mm and an outer diameter of 40 mm. This procedure induces secondary pinprick hyperalgesia (an increase in pinprick sensitivity in a large area of the skin).
Eligibility Criteria
You may qualify if:
- Females aged between 18 and 50 years.
- BMI between 17 and 30.
- Ability to provide written informed consent.
You may not qualify if:
- Evidence of psychiatric/inflammatory/neurological or metabolic comorbidities on direct questioning as this study is meant to focus on musculoskeletal disorders.
- Evidence of skin alteration on the volar forearms that may interfere with HFS.
- Any substance abuse, or the use of antidepressant or neuroleptic medication as these may interfere with the psychophysical examination.
- Any painful musculoskeletal disorder.
- Lack of dental check-ups during the last 12 months.
- Females aged between 18 and 50 years.
- BMI between 17 and 30.
- Ability to provide written informed consent.
- Chronic TMD (for at least 3 months) as a main complain (according to the DC/TMD), with an average of at least 3/10 on a pain numerical rating scale during the past month in the orofacial region.
- Evidence of psychiatric/inflammatory/neurological or metabolic comorbidities on direct questioning as this study is meant to focus on musculoskeletal disorders.
- Evidence of skin alteration on the volar forearms that may interfere with HFS.
- Any substance abuse, or the use of antidepressant or neuroleptic medication as these may interfere with the psychophysical examination.
- Lack of dental check-ups during the last 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cliniques universitaires St-Luc
Brussels, 1200, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2019
First Posted
September 12, 2019
Study Start
January 11, 2021
Primary Completion
March 29, 2022
Study Completion
March 29, 2022
Last Updated
April 7, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share